Searching the Resource Information Network

Our searching services are busy right now. Please try again later

  • Register
X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X

Leaving Community

Are you sure you want to leave this community? Leaving the community will revoke any permissions you have been granted in this community.

No
Yes
Norway

PMID:14707116  

BCMA is essential for the survival of long-lived bone marrow plasma cells.

Brian P O'Connor | Vanitha S Raman | Loren D Erickson | W James Cook | Lehn K Weaver | Cory Ahonen | Ling-Li Lin | George T Mantchev | Richard J Bram | Randolph J Noelle
The Journal of experimental medicine | 2004

Long-lived humoral immunity is manifested by the ability of bone marrow plasma cells (PCs) to survive for extended periods of time. Recent studies have underscored the importance of BLyS and APRIL as factors that can support the survival of B lineage lymphocytes. We show that BLyS can sustain PC survival in vitro, and this survival can be further enhanced by interleukin 6. Selective up-regulation of Mcl-1 in PCs by BLyS suggests that this alpha-apoptotic gene product may play an important role in PC survival. Blockade of BLyS, via transmembrane activator and cyclophilin ligand interactor-immunoglobulin treatment, inhibited PC survival in vitro and in vivo. Heightened expression of B cell maturation antigen (BCMA), and lowered expression of transmembrane activator and cyclophilin ligand interactor and BAFF receptor in PCs relative to resting B cells suggests a vital role of BCMA in PC survival. Affirmation of the importance of BCMA in PC survival was provided by studies in BCMA-/- mice in which the survival of long-lived bone marrow PCs was impaired compared with wild-type controls. These findings offer new insights into the molecular basis for the long-term survival of PCs.

Pubmed ID: 14707116

Research resources used in this publication

None found

Antibodies used in this publication

None found

Associated grants

  • Agency: NCRR NIH HHS, United States
    Id: P20 RR016437
  • Agency: NIAID NIH HHS, United States
    Id: R37 AI026296
  • Agency: NIAID NIH HHS, United States
    Id: AI 26296
  • Agency: NCI NIH HHS, United States
    Id: R01 CA076274
  • Agency: NCRR NIH HHS, United States
    Id: P20 RR 16437
  • Agency: NCI NIH HHS, United States
    Id: CA 076274
  • Agency: NIAID NIH HHS, United States
    Id: R01 AI026296

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.


US Biological (tool)

RRID:SCR_013653

An Antibody supplier

View all literature mentions

BALB/cAnNCrl (tool)

RRID:MGI:2683685

laboratory mouse with name BALB/cAnNCrl from MGI.

View all literature mentions

C57BL/6J (tool)

RRID:IMSR_JAX:000664

Mus musculus with name C57BL/6J from IMSR.

View all literature mentions